Aadi Bioscience Inc. (AADI)
NASDAQ: AADI
· Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM
Aadi Bioscience Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -52.62M | 73.02M | -18.27M | -12.55M | -14.58M | -18.29M | -16.27M | -16.3M | -17.97M | -15.22M | -13.91M | -14.47M | -18.27M | -13.86M | -15.99M | -87.09M | -1.54M | -5.48M |
Depreciation & Amortization | 2K | 57K | 47K | 47K | 49K | 50K | 44K | 44K | 43K | 38K | 46K | 12K | 27K | 74K | 72K | 29K | 2K | 2K |
Stock-Based Compensation | 3.09M | 1.68M | 1.85M | 9.1M | 2.84M | 3.59M | 3.11M | 3.05M | 3.05M | 2.74M | 2.87M | 2.76M | 2.23M | 1.78M | 1.38M | 648K | 39K | 36K |
Other Working Capital | n/a | 1.56M | 630K | 4.93M | 1.46M | 965K | 1.02M | 1.73M | 1.52M | 7.19M | -5.98M | -1.16M | 277K | -498K | -1.44M | 150.45M | 485K | 38.87M |
Other Non-Cash Items | -3.43M | -87.35M | -106K | -6.75M | 115K | 9.16M | 9K | 115K | 115K | -1.03M | -954K | -151K | 148K | 124K | 119K | 177K | 272K | 268K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -380K | -588K | -862K | n/a | n/a | n/a | n/a | n/a | n/a | 73.78M | -2.57M | 1.17M |
Change in Working Capital | n/a | 733K | 1.43M | -5.53M | 2.81M | -4.75M | 3.84M | 1.73M | -1.14M | -7.84M | 641K | 3.66M | 1.42M | -7.54M | 1.99M | -4.92M | 605K | 14.57M |
Operating Cash Flow | -52.96M | -11.86M | -15.05M | -15.69M | -9.16M | -19.65M | -9.64M | -11.95M | -16.76M | -21.31M | -11.31M | -8.2M | -10.72M | -19.41M | -12.43M | -17.37M | -3.19M | 10.56M |
Capital Expenditures | -1K | -551K | -186K | -188K | -541K | -739K | -816K | -1.1M | -689K | -1.37M | -78K | -102K | -241K | -23K | -46K | n/a | n/a | n/a |
Cash Acquisitions | n/a | 101.36M | n/a | n/a | n/a | n/a | -4.46M | -13.77M | n/a | -17.7M | 84.3M | n/a | n/a | n/a | n/a | 25.36M | -157K | n/a |
Purchase of Investments | -32.22M | n/a | 1K | -36.48M | -18.91M | -7.65M | -13.9M | -27.49M | n/a | -23.05M | -97.05M | -48.14M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 3.39M | 14.69M | 13.32M | 15.2M | 15.88M | 18.94M | 18.36M | 41.26M | 51.25M | 40.75M | 12.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 24.1M | -3.03M | 11.29M | 4.46M | 13.77M | 51.25M | 17.7M | -84.3M | -48.14M | n/a | n/a | n/a | -4.5M | n/a | n/a |
Investing Cash Flow | -28.83M | 115.5M | 13.13M | 5.08M | -3.57M | 10.55M | 3.65M | 12.67M | 50.56M | 16.33M | -84.38M | -48.24M | -241K | -23K | -46K | 25.36M | -157K | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 24K | n/a | n/a | 94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.41M | n/a | n/a |
Other Financial Acitivies | -850K | -4.8M | 53K | -24.36M | 87K | -10K | 80K | -75K | 313K | 8K | -107K | 72.52M | -87K | 298K | 88K | 146.13M | -1K | n/a |
Financial Cash Flow | -850K | 95.2M | 53K | -24.36M | 87K | -10K | 80K | -75K | 313K | 8K | -107K | 72.52M | -87K | 298K | 88K | 141.72M | -1K | 70.28K |
Net Cash Flow | -82.63M | 198.84M | -1.87M | -10.6M | -12.64M | -9.11M | -5.92M | 641K | 34.12M | -4.97M | -95.8M | 16.08M | -11.05M | -19.14M | -12.39M | 149.7M | -3.34M | 10.56M |
Free Cash Flow | -52.96M | -12.41M | -15.24M | -15.88M | -9.7M | -20.39M | -10.46M | -13.05M | -17.45M | -22.68M | -11.39M | -8.3M | -10.96M | -19.44M | -12.47M | -17.37M | -3.19M | 10.56M |